FIELD: medicine.
SUBSTANCE: method involves introducing anecortavi acetas at a dose of 3-15 mg in posterior juxtascleral injection or injection into vitreous body or as implant.
EFFECT: enhanced effectiveness of treatment.
18 cl, 5 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED METHOD FOR TREATING CHOROIDAL NEOVASCULATION OF ALL TYPES | 2021 |
|
RU2770745C1 |
| METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
| METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | 2009 |
|
RU2668371C2 |
| METHOD FOR CHOOSING TACTICS FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY COMPLICATED BY TYPE 1 CHOROIDAL NEOVASCULARIZATION | 2022 |
|
RU2788279C1 |
| APPLICATION OF ANTAGONIST VEGF IN TREATMENT OF CHORIORETINAL NEOVASCULAR DISTURBANCES AND DISORDERS OF PENETRATION IN PEDIATRIC PATIENTS | 2014 |
|
RU2676274C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF MYOPIC CHOROIDAL NEOVASCULARIZATION AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN MYOPIC EYES | 2020 |
|
RU2749120C1 |
| METHOD FOR COMBINED TREATMENT OF MACULAR OEDEMA OF RETINA | 2015 |
|
RU2622031C1 |
| METHOD FOR TREATMENT OF MACULAR EDEMA OF RETINA | 2016 |
|
RU2635530C1 |
| METHOD OF QUANTITATIVE ESTIMATION OF CLINICAL EFFECTIVENESS OF PHOTODYNAMIC THERAPY IN CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2387471C1 |
| METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
